Big data and machine learning to tackle diabetes management.
Ana F Pina1,2, Maria João Meneses1,3,4, Inês Sousa-Lima1
1iNOVA4Health, NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.
European Journal of Clinical Investigation
|October 18, 2022
Summary
Cluster analysis can reveal Type 2 Diabetes (T2D) heterogeneity by integrating diverse patient data. This approach enables personalized prevention and treatment strategies for better diabetes management and complication avoidance.
Area of Science:
- Metabolic Diseases
- Biostatistics
- Personalized Medicine
Background:
- Type 2 Diabetes (T2D) diagnosis relies solely on glycaemia, overlooking its complex dysmetabolic pathways.
- The heterogeneity of T2D presents challenges for real-world management, necessitating methods to dissect its complexity.
- Cluster analysis offers a promising approach to identify natural groupings within multidimensional data for understanding diabetes complexity.
Purpose of the Study:
- To review and integrate existing research on cluster analysis applications in Type 2 Diabetes (T2D).
- To explore how cluster analysis can unravel the heterogeneity of T2D.
- To propose a framework for a more holistic interpretation of individual diabetes pathology.
Main Methods:
- Systematic review and integration of studies on cluster analysis and T2D.
- Analysis of parameters used in existing cluster analysis for T2D stratification.
- Development of a theoretical Integrative Model for T2D profiling.
Main Results:
- Cluster analysis requires more parameters than traditional ones (e.g., etiological factors, pathophysiological mechanisms, comorbidities, biochemical milieu) for accurate subject stratification.
- These additional factors significantly impact diabetes progression and complications.
- The proposed Integrative Model categorizes factors into etiological, mechanistic, and milieu components for holistic interpretation.
Conclusions:
- Comprehensive individual profiling, including genomic, environmental, and temporal exposure factors, is crucial for advancing precision medicine in diabetes.
- This holistic approach will drive the prevention of diabetes complications.
- Personalized prevention and therapeutic strategies are essential for effective diabetes management.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
337
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
337
Diabetes Mellitus: Type 2 and Gestational
2.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K
Diabetes Mellitus: Overview and Type I Subtype
2.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.9K
Diabetes: Symptoms, Diagnosis, and Complications
657
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
657
Carbohydrate Metabolism
11.5K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.5K
Pathophysiology of Diabetes
1.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K


